{"organizations": [], "uuid": "473f9e647a27aa3928f2d553a31dffdf0811f487", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-concert-pharma-says-fda-granted-fa/brief-concert-pharma-says-fda-granted-fast-track-designation-to-ctp-543-idUSASB0C0T3", "country": "US", "domain_rank": 408, "title": "BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-12T14:13:00.000+02:00", "replies_count": 0, "uuid": "473f9e647a27aa3928f2d553a31dffdf0811f487"}, "author": "", "url": "https://www.reuters.com/article/brief-concert-pharma-says-fda-granted-fa/brief-concert-pharma-says-fda-granted-fast-track-designation-to-ctp-543-idUSASB0C0T3", "ord_in_thread": 0, "title": "BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "brief-concert pharma", "sentiment": "negative"}, {"name": "concert pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "alopecia areata", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 14 PM / Updated 7 minutes ago BRIEF-Concert Pharma Says FDA Granted Fast Track Designation To CTP-543 Reuters Staff \nJan 12 (Reuters) - Concert Pharmaceuticals Inc: \n* FDA GRANTS FAST TRACK DESIGNATION TO CONCERT PHARMACEUTICALS’ CTP-543 FOR THE TREATMENT OF ALOPECIA AREATA \n* CONCERT PHARMA SAYS U.S. FDA GRANTED FAST TRACK DESIGNATION FOR CO‘S CTP-543 Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-12T14:13:00.000+02:00", "crawled": "2018-01-12T14:28:14.023+02:00", "highlightTitle": ""}